#78: Use of Isavuconazonium for Treatment Of Invasive Fungal Infection in Immunocompromised Pediatric Patients
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Pediatric Infectious Diseases Society"
DOI: 10.1093/jpids/piaa170.006
Abstract: Isavuconazole (ISZ), dosed as the pre-drug isavuconazonium (ISM), is active against a wide variety of clinically important fungal pathogens. ISM is approved for the treatment of invasive aspergillosis and mucormycosis in adults ≥18 years of… read more here.
Keywords: pediatric patients; ism; fungal infection; treatment invasive ... See more keywords
Mycobacterium marinum infection in an immunocompromised patient with infliximab
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2020.3804
Abstract: EJD, vol. 30, n◦ 4, July-August 2020 areas affected by seborrheic dermatitis or psoriasis of the scalp [6]. Several reports described the coexistence of AA and psoriasis, with psoriatic lesions that tended to be spared… read more here.
Keywords: marinum infection; mycobacterium marinum; hair; patient infliximab ... See more keywords
Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021
Sign Up to like & getrecommendations! Published in 2023 at "Emerging Infectious Diseases"
DOI: 10.3201/eid2905.221638
Abstract: Infection with Borrelia miyamotoi in California, USA, has been suggested by serologic studies. We diagnosed B. miyamotoi infection in an immunocompromised man in California. Diagnosis was aided by plasma microbial cell–free DNA sequencing. We conclude… read more here.
Keywords: miyamotoi infection; infection; borrelia miyamotoi; california usa ... See more keywords